← brief for 2026-10-11 · Slowing decline

Current review of glucagon-like peptide 1 receptor agonists and risk of nonarteritic anterior ischemic optic neuropathy.

Paper No results yet Peer reviewed

Key takeaways

This review looks at a possible link between weight-loss drugs and vision loss. It is a summary of what is already known. There are no new results from this piece. It helps doctors weigh the risks.

Who did this work

Ruan F · Gnana B · Mei C · Gong W · Limaye S · Kim D · Person EA

Source

Paper · PubMed, the drug frontier · 2026 Oct 1
https://pubmed.ncbi.nlm.nih.gov/42857401/